» Articles » PMID: 31986212

Asherman's Syndrome: It May Not Be All Our Fault

Overview
Journal Hum Reprod
Date 2020 Jan 28
PMID 31986212
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Asherman's Syndrome (AS) is an acquired condition defined by the presence of intrauterine adhesions (IUA) that cause symptoms such as menstrual abnormalities, pelvic pain, infertility, recurrent miscarriage, abnormal placentation and attendant psychological distress. Classically, AS is considered an iatrogenic disease triggered by trauma to the pregnant uterus. Different factors can cause the destruction of the endometrium, thus affecting the endometrial stem cell niche and creating IUAs. Curettage of the pregnant uterus appears to be the most common source of this destruction. Nevertheless, some AS cases have been associated with congenital uterine abnormalities and infections, and there are some idiopathic cases without any prior surgical procedures, suggesting a putative constitutional predisposition to IUA. Factors reported to cause AS share an underlying inflammatory mechanism leading to defective endometrial healing and vascularization. Interestingly, distinct genetic profiles have been observed in the endometrium of AS patients. These data suggest that AS might not just be an iatrogenic complication, but also the result of a genetic predisposition. Elucidating the possible physiopathological processes that contribute to AS will help to identify patients at risk for this condition, providing an opportunity for prevention.

Citing Articles

Enhanced myofibroblast differentiation of eMSCs in intrauterine adhesions.

Song J, Li M, Tao Y, Li Y, Mai C, Zhang J Stem Cell Res Ther. 2025; 16(1):35.

PMID: 39901307 PMC: 11792338. DOI: 10.1186/s13287-025-04183-y.


Long-term therapeutic effects of allogeneic mesenchymal stem cell transplantation for intrauterine adhesions.

Chen K, Gao Y, Xia N, Liu Y, Wang H, Ma H Stem Cell Res Ther. 2024; 15(1):499.

PMID: 39716301 PMC: 11668121. DOI: 10.1186/s13287-024-04100-9.


Association between first-trimester subchorionic hematoma and pregnancy loss before 20 weeks of gestation in singleton pregnancies.

Lou Y, Chen G, Wang L, Zhao X, Ma J Sci Rep. 2024; 14(1):30034.

PMID: 39627519 PMC: 11615346. DOI: 10.1038/s41598-024-81759-3.


Improvement of endometrial thickness and fertilization outcomes in patients with Asherman's refractory endometrium using autologous mesenchymal stem cells from the stromal vascular fraction.

Hernandez-Melchor D, Ortiz G, Madrazo I, Suarez J, Barrera N, Porchia L Am J Transl Res. 2024; 16(8):4020-4031.

PMID: 39262711 PMC: 11384418. DOI: 10.62347/UAGF1249.


Mechanism of Smilax china L. in the treatment of intrauterine adhesions based on network pharmacology, molecular docking and experimental validation.

Shi T, Hou C, Duan Y, Li Y, Liu W, Huang P BMC Complement Med Ther. 2024; 24(1):150.

PMID: 38580999 PMC: 10996135. DOI: 10.1186/s12906-024-04414-4.